Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-07-02

Clinical Trial Update: Structure of the Herpes Simplex Virus Receptor

View source ↗

Summary

This update reports on research into the structure of the receptor used by herpes simplex virus and its implications for antiviral targeting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Encephalitis, Herpes Simplex | Status: COMPLETED